# Phase 2 tuberculosis trials recruiting: 26 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials in phase 2 for tuberculosis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 tuberculosis trials: 26 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/tuberculosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 26
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 26, 2026 | NCT07893444 | BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children | Huashan Hospital | Phase 2 | Recruiting | Tuberculosis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893444) |
| August 19, 2026 | NCT07773610 | Study of Combinations of Novel Promising Drugs for Pulmonary Tuberculosis | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Tuberculosis, Pulmonary | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773610) |
| August 13, 2026 | NCT07762014 | rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older | Biothervax SpA | Phase 2 | Recruiting | Respiratory Syncytial Virus Infection Prevention, Tuberculosis Prevention | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762014) |
| June 26, 2026 | NCT07672405 | Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB | Global Alliance for TB Drug Development | Phase 2 | Recruiting | Tuberculosis, Pulmonary | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07672405) |
| June 18, 2026 | NCT07656012 | Re-evaluating the Duration in Children of TB Treatment | University of Wisconsin, Madison | Phase 2 | Not yet recruiting | Tuberculosis | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07656012) |
| May 19, 2026 | NCT07595042 | A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Not yet recruiting | Tuberculosis | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595042) |
| March 12, 2026 | NCT07467252 | AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT | Ministry of Health, Saudi Arabia | Phase 2 | Not yet recruiting | Pulmonary Tuberculosis | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07467252) |
| February 6, 2026 | NCT07393438 | Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS) | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 | Not yet recruiting | Multidrug-Resistant Tuberculosis, Rifampicin-resistant Tuberculosis, MDR-TB, RR-TB | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07393438) |
| January 20, 2026 | NCT07350174 | Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis | BioVersys AG | Phase 2 | Not yet recruiting | Tuberculosis Meningitis | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07350174) |
| December 26, 2025 | NCT07303699 | ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD) | Obafemi Awolowo University Teaching Hospital | Phase 2 | Recruiting | Pulmonary Tuberculosis (TB) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07303699) |
| November 13, 2025 | NCT07227779 | BPaLMZ for TB Meningitis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Tuberculous Meningitis, HIV, Meningitis, TB - Tuberculosis | 312 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07227779) |
| September 12, 2025 | NCT07170800 | A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets | WestVac Biopharma Co., Ltd. | Phase 2 | Recruiting | Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07170800) |
| August 19, 2025 | NCT07129629 | Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 | Not yet recruiting | Tuberculosis, Pulmonary, Drug-Susceptible Pulmonary Tuberculosis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07129629) |
| August 12, 2025 | NCT07118059 | Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and... | North-West University, South Africa | Phase 2 | Recruiting | Tuberculosis, Inflammation Biomarkers, Liver Function Tests, Iron Status, Metabolomics, Nutritional Status, Clinical... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07118059) |
| July 18, 2025 | NCT07073638 | Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis | Thirty Respiratory Limited | Phase 2 | Recruiting | Pulmonary Tuberculoses | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07073638) |
| December 27, 2024 | NCT06748937 | A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide | Sponsor not shown (see the record) | Phase 2 | Recruiting | Tuberculosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06748937) |
| June 27, 2024 | NCT06477185 | Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline | Makerere University | Phase 2 | Recruiting | Tuberculosis, Pulmonary | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06477185) |
| June 6, 2024 | NCT06446245 | Adjunctive Doxycycline for Central Nervous System Tuberculosis | National University Hospital, Singapore | Phase 2 | Recruiting | Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology), Tuberculosis, Central Nervous System, Tuberculosis... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06446245) |
| January 16, 2024 | NCT06205589 | Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Phase 2 | Not yet recruiting | Tuberculosis, Pulmonary | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06205589) |
| January 10, 2024 | NCT06199921 | ATORvastatin in Pulmonary TUBerculosis | Obafemi Awolowo University Teaching Hospital | Phase 2 | Recruiting | Pulmonary Tuberculosis, Tuberculosis, Koch's Disease | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06199921) |
| November 2, 2023 | NCT06114628 | Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB | University College, London | Phase 2 | Recruiting | Pulmonary Tuberculosis | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06114628) |
| July 17, 2023 | NCT05947890 | Evaluating the Safety and Immunogenicity of MTBVAC | HIV Vaccine Trials Network | Phase 2 | Recruiting | HIV I Infection, Tuberculosis | 276 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05947890) |
| April 11, 2023 | NCT05807399 | PanACEA - STEP2C -01 | Sponsor not shown (see the record) | Phase 2 | Recruiting | Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis | 390 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05807399) |
| October 21, 2022 | NCT05590455 | Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis | ANRS, Emerging Infectious Diseases | Phase 2 | Recruiting | Tuberculous Meningitis, HIV I Infection | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05590455) |
| September 9, 2022 | NCT05534750 | Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) | Assistance Publique - Hôpitaux de Paris | Phase 2 | Recruiting | Tuberculosis, Multidrug Resistant Tuberculosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05534750) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Obafemi Awolowo University Teaching Hospital | 2 |
| Shanghai Pulmonary Hospital, Shanghai, China | 2 |
| HIV Vaccine Trials Network | 1 |
| Huashan Hospital | 1 |
| University of Wisconsin, Madison | 1 |
| Makerere University | 1 |
| University College, London | 1 |
| National University Hospital, Singapore | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 1 |
| North-West University, South Africa | 1 |
| ANRS, Emerging Infectious Diseases | 1 |
| WestVac Biopharma Co., Ltd. | 1 |
| Biothervax SpA | 1 |
| Thirty Respiratory Limited | 1 |
| Global Alliance for TB Drug Development | 1 |
| Ministry of Health, Saudi Arabia | 1 |
| BioVersys AG | 1 |

## By country

| Country | Trials |
| --- | --- |
| South Africa | 9 |
| Uganda | 5 |
| Tanzania | 5 |
| China | 3 |
| Peru | 3 |
| Brazil | 3 |
| Malawi | 3 |
| Vietnam | 3 |
| India | 2 |
| Kenya | 2 |
| Mexico | 2 |
| Philippines | 2 |
| Thailand | 2 |
| Zimbabwe | 2 |
| Mozambique | 2 |
| Nigeria | 2 |
| Argentina | 1 |
| Australia | 1 |
| Botswana | 1 |
| Haiti | 1 |
| Moldova | 1 |
| Gabon | 1 |
| Indonesia | 1 |
| Malaysia | 1 |
| Singapore | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Litigation law firms in the United States](https://specstream.ai/data/businesses/litigation-law-firms/united-states)
- [Gardening services in the United States](https://specstream.ai/data/businesses/gardening-services/united-states)
- [Credit and debt counseling services in the United States](https://specstream.ai/data/businesses/credit-and-debt-counseling-services/united-states)
- [B2B transportation and storage companies in the United States](https://specstream.ai/data/businesses/b2b-transportation-and-storage-companies/united-states)
- [Vehicle parts manufacturers in the United States](https://specstream.ai/data/businesses/vehicle-parts-manufacturers/united-states)
- [Retina services clinics in the United States](https://specstream.ai/data/businesses/retina-services-clinics/united-states)
